RevBio has received approval from the US Food and Drug Administration (FDA) to initiate a pilot dental clinical trial evaluating the safety and efficacy of its regenerative bone adhesive, Tetranite.
The study will assess the use of Tetranite in dental ridge augmentation procedures, with the aim of enabling bone grafting...